NCT02603770View on ClinicalTrials.gov

Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

February 29, 2016

Conditions
Lipid Metabolism Disorder
Interventions
DRUG

XueZhiKang

DRUG

Lovastatin

Trial Locations (1)

92868

NRC Research Institute, Orange

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT02603770 - Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter